Document 0665 DOCN M9490665 TI The 2-5A system and HIV infection. DT 9411 AU Schroder HC; Kelve M; Muller WE; Abteilung Angewandte Molekularbiologie, Johannes; Gutenberg-Universitat, Mainz, Germany. SO Prog Mol Subcell Biol. 1994;14:176-97. Unique Identifier : AIDSLINE MED/94340158 AB 2',5'-Oligoadenylates (2-5A) have an essential role in the establishment of the antiviral state of a cell exposed to virus infection. The key enzymes of the 2-5A system are the 2-5A forming 2',5'-oligoadenylate synthetase (2-5OAS), the activity of which depends on the presence of viral or cellular double-stranded RNA (dsRNA), and the 2-5A-activated ribonuclease (RNase L). Basic research in recent years has shown that the 2-5A system is a promising target for anti-HIV chemotherapy, particularly due to its interaction with double-stranded segments within HIV RNA. Two new strategies have been developed which yield a selective antiviral effect of 2-5A against HIV-1 infection: (1) development of 2-5A analogues displaying a dual mode of action (activation of RNase L and inhibition of HIV-1 RT) and (2) intracellular immunization of cells against HIV-1 infection by application of the HIV-1-LTR--2-5OAS hybrid gene. A further strategy is the inhibition of DNA topoisomerase I by longer 2-5A oligomers. DE Acquired Immunodeficiency Syndrome/DRUG THERAPY/*METABOLISM Adenine Nucleotides/*METABOLISM/TOXICITY *Antiviral Agents/TOXICITY AIDS-Related Complex/DRUG THERAPY/METABOLISM Bacterial Proteins/METABOLISM Cell Line Endoribonucleases/METABOLISM Enzyme Activation Gene Products, tat/METABOLISM Human HIV Infections/DRUG THERAPY/*METABOLISM HIV-1/DRUG EFFECTS/*PHYSIOLOGY Membrane Proteins/METABOLISM Oligoribonucleotides/*METABOLISM/TOXICITY Protein-Serine-Threonine Kinases/METABOLISM Support, Non-U.S. Gov't Thionucleotides/TOXICITY 2',5'-Oligoadenylate Synthetase/METABOLISM JOURNAL ARTICLE REVIEW REVIEW, ACADEMIC SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).